Wang B X, Yang M, Jin Y L, Liu P
Department of Pharmacology, Academy of Traditional Chinese Medicine, Changchun.
Yao Xue Xue Bao. 1990;25(10):727-31.
When ginseng polypeptide (GP) was administered iv or sc to mice or rats, the blood sugar and liver glycogen were decreased. The decrease of blood sugar and liver glycogen induced by GP in rats were inhibited by pretreatments with pentolamine and propranolol, respectively. The results suggest that the effect of GP on glucose metabolism may be related to adrenergic receptors. In addition, GP at doses which cause decreases of blood sugar and glycogen, inhibited LDH activity, and consequently produced decrease of lactic acid and increase of pyruvic acid. GP was also found to stimulate SDH and CCO activities (which are respiratory enzymes in the electron transport chain), consequently promote aerobic oxidation course.
当给小鼠或大鼠静脉注射或皮下注射人参多肽(GP)时,血糖和肝糖原会降低。分别用酚妥拉明和普萘洛尔预处理可抑制GP诱导的大鼠血糖和肝糖原降低。结果表明,GP对糖代谢的影响可能与肾上腺素能受体有关。此外,能引起血糖和糖原降低剂量的GP抑制了乳酸脱氢酶(LDH)活性,从而导致乳酸减少和丙酮酸增加。还发现GP能刺激琥珀酸脱氢酶(SDH)和细胞色素氧化酶(CCO)活性(它们是电子传递链中的呼吸酶),从而促进有氧氧化过程。